الرسائل الموجهة للمختصين الصحيين

Hemophagocytic syndrome (HPS) reported in patients treated with  Gilenya®. 

Risk of capillary leak syndrome in patients with cancer.  ​

Updated information on posology for intravenous use and dose dependant QT interval prolongation.  

Risk of Thromboembolism.  

The management of hepatitis B reactivation in patients treated with MabThera®.  CLICK HERE​

Important Safety Update of Prescribing Information for LARIAM®. 

 

Fenatnyl‐Janssen Introduction of New Warning ‐ Serontonin syndrome may occur under co‐administration with serotonergic drugs.  

 

Introduction of New Warning-Serontonin syndrome may occur under co-administration with serotonergic drugs.  

 

Important change to frequency of Serum liver test monitoring for hepatotoxicity.  

 

Updated information regarding the possible risk of developing atherosclerosis-related diseases with the use of TASIGNA®.  ​